We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Ketamine for Depression Still Too Expensive for Widespread Use

News   Jul 14, 2020 | Original story from McLean Hospital

 
Ketamine for Depression Still Too Expensive for Widespread Use
 
 
Advertisement
 

RELATED ARTICLES

Patients Taking Certain HIV Drugs Had a 33% Lower Risk of Developing Diabetes

News

A group of drugs used to treat HIV and hepatitis B could be repurposed to prevent Type 2 diabetes, according to a newly published study.

READ MORE

ELRIG UK Elects Melanie Leveridge To Lead the Organisation as Chair

News

The European Laboratory Research & Innovation Group (ELRIG) UK, today announced the election of Melanie Leveridge as Chair. Melanie will guide the not-for-profit organisation serving the life science and drug discovery communities, to help drive further collaboration and knowledge exchange between academic and biopharma industry thought-leaders, through the provision of scientific meetings and conferences on an open access basis.

READ MORE

Protein Tracer Could Help Track Parkinson's Progression

News

A new study describes an innovative approach for identifying molecules that can help track the progression of Parkinson's disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE